Evidence map›Paper›PMID 32213076›Full record

Observational studyUnited European gastroenterology journal2020

Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research.

Friederike Weise, Michael Vieth, Dirk Reinhold, Johannes Haybaeck, Elisabetta Goni, Hans Lippert, Karsten Ridwelski, Philipp Lingohr, Claus Schildberg, Nikolaos Vassos and 15 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in United European gastroenterology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Gastric cancer in patients withWorld journal of gastrointestinal oncology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Clinicopathological characteristics of early gastric cancer associated with autoimmune gastritis.JGH open : an open access journal of gastroenterology and hepatology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 16 institutions in 2 countries.

Friederike WeiseDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Michael ViethInstitute of Pathology, Klinikum Bayreuth, Bayreuth, Germany.
Dirk ReinholdInstitute of Molecular and Clinical Immunology, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Johannes HaybaeckDepartment of Pathology, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Elisabetta GoniDepartment of Internal Medicine II, Hospital of the Ludwig Maximilians University of Munich, Munich, Germany.
Hans LippertInstitute of Quality Assurance in Operative Medicine, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Karsten RidwelskiDepartment of General and Visceral Surgery, Klinikum Magdeburg GmbH, Magdeburg, Germany.
Philipp LingohrDepartment of General, Visceral, Thoracic and Vascular Surgery, University Hospital Bonn, Bonn, Germany.
Claus SchildbergDepartment of General and Visceral Surgery, Pius Klinikum, University Hospital of Visceral Surgery, Oldenburg, Germany.
Nikolaos VassosDivision of Surgical Oncology and Thoracic Surgery, Department of Surgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Martin KruschewskiDepartment of General and Visceral Surgery, Klinikum Frankfurt (Oder), Germany.
Iurii KrasniukDepartment of General, Visceral and Thoracic Surgery, Städtisches Klinikum Solingen GmbH, Solingen, Germany.
Peter P GrimmingerDepartment of General, Visceral and Transplant Surgery, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Oliver WaidmannDepartment of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Ulrich PeitzDepartment of Gastroenterology, Raphaelsklinik, Münster, Germany.
Lothar VeitsInstitute of Pathology, Klinikum Bayreuth, Bayreuth, Germany.
Nicole KreuserDepartment of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.
Hauke LangDepartment of General, Visceral and Transplant Surgery, University Medical Center, University of Mainz, Mainz, Germany.
Christiane BrunsDepartment of General, Visceral and Tumor Surgery, University Hospital Cologne, Cologne, Germany.
Markus MoehlerDepartment of Internal Medicine I, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Florian LordickUniversity Cancer Center Leipzig, University Hospital Leipzig, Leipzig, Germany.
Ines GockelDepartment of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.
Johannes SchumacherHuman Genetics Center, Philipps University of Marburg, Marburg, Germany.
Peter MalfertheinerDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Marino VeneritoDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.ORCID 0000-0001-8581-0974
University Hospital Magdeburg · DEJohannes Gutenberg University Mainz · DEUniversity Hospital Leipzig · DEBayreuth Medical Center · DEGoethe University Frankfurt · DEHeidelberg University · DEInnsbruck Medical University · ATKlinikum Frankfurt Höchst · DEKlinikum Magdeburg · DELudwig-Maximilians-Universität München · DEPhilipps University of Marburg · DEPius Hospital Oldenburg · DERaphaelsklinik Münster · DEStädtisches Klinikum Solingen · DEUniversity Hospital Bonn · DEUniversity Hospital Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPatients with autoimmune gastritis (AIG) are reported to have an increased risk of developing gastric cancer (GC). In this study, we assess the characteristics and outcomes of GC patients with AIG in a multicenter case-control study.

methodsBetween April 2013 and May 2017, patients with GC, including cancers of the esophagogastric junction (EGJ) Siewert type II and III, were recruited. Patients with histological characteristics of AIG were identified and matched in a 1:2 fashion for age and gender to GC patients with no AIG. Presenting symptoms were documented using a self-administered questionnaire.

resultsHistological assessment of gastric mucosa was available for 572/759 GC patients. Overall, 28 (4.9%) of GC patients had AIG (67 ± 9 years, female-to-male ratio 1.3:1). In patients with AIG, GC was more likely to be localized in the proximal (i.e. EGJ, fundus, corpus) stomach (odds ratio (OR) 2.7, 95% confidence interval (CI) 1.0-7.1). In GC patients with AIG, pernicious anemia was the leading clinical sign (OR 22.0, 95% CI 2.6-187.2), and the most common indication for esophagogastroduodenoscopy (OR 29.0, 95% CI 7.2-116.4). GC patients with AIG were more likely to present without distant metastases (OR 6.2, 95% CI 1.3-28.8) and to be treated with curative intention (OR 3.0, 95% CI 1.0-9.0). The five-year survival rates with 95% CI in GC patients with and with no AIG were 84.7% (83.8-85.6) and 53.5% (50.9-56.1), respectively (OR 0.25, 95% CI 0.08-0.75,

conclusionsPernicious anemia leads to earlier diagnosis of GC in AIG patients and contributes significantly to a better clinical outcome.

Indexed as

AgedAnemia, PerniciousAutoantibodiesAutoimmune DiseasesCase-Control StudiesEndoscopy, Digestive SystemFemaleGastric MucosaGastritisHumansIntrinsic FactorMaleMiddle AgedParietal Cells, GastricRisk AssessmentRisk FactorsAutoantibodiesIntrinsic Factorautoimmune gastritisGastric cancerHelicobacter pylorisurvivalsymptoms

Identifiers

PMID32213076
PMCPMC7079279
OpenAlexW2990503755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.